UroGen PharmaURGN
那斯達克 · USD
46.39
+2.58
(+5.88%)
盤中 09/09 11:37 (UTC+8)
09/09 11:37 (UTC+8)
UroGen PharmaURGN
46.39
+2.58
(+5.88%)
財務數據
損益表
- 0.19
- 0.22
- 0.25
- 0.25
- 0.20
- 0.24
- 0.27
- 0.38
- 0.51
- 0.72
- -20.18
- 16.33
- 15.36
- -2.54
- -17.55
- 19.56
- 13.49
- 37.68
- 34.68
- 42.18
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 72,456 | 50,959 | 37,837 | 27,482 | 24,215 | 20,254 | 24,565 | 25,204 | 21,848 | 18,781 |
營業成本 | 6,572 | 4,139 | 3,289 | 3,278 | 3,550 | 2,330 | 2,471 | 2,453 | 2,229 | 1,728 |
營業毛利 | 65,884 | 46,820 | 34,548 | 24,204 | 20,665 | 17,924 | 22,094 | 22,751 | 19,619 | 17,053 |
營業費用 | 65,773 | 67,083 | 53,663 | 51,590 | 62,113 | 54,838 | 49,752 | 40,296 | 45,458 | - |
研發費用 | 17,336 | 15,597 | 14,314 | 14,008 | 18,914 | 19,871 | 14,894 | 11,355 | 15,402 | 15,494 |
推銷及管理費用 | 48,437 | 51,486 | 39,349 | 37,582 | 43,199 | 34,967 | 34,858 | 28,941 | 30,056 | 27,299 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 111 | -20,263 | -19,115 | -27,386 | -41,448 | -36,914 | -27,658 | -17,545 | -25,839 | -25,740 |
其他收入及費用 | -3,946 | -3,898 | -3,752 | -3,642 | -3,345 | -2,469 | -3,313 | -3,316 | -4,065 | -4,045 |
利息費用 | 4,887 | 4,185 | 3,772 | 3,373 | 4,132 | 4,068 | 3,892 | 2,721 | 3,461 | 2,447 |
稅前純益 | -8,722 | -28,346 | -26,639 | -34,401 | -48,925 | -43,451 | -34,863 | -23,582 | -33,365 | -32,232 |
所得稅 | 5,629 | -4,772 | -275 | -1,054 | 1,015 | 392 | 2,649 | 91 | 38 | 54 |
稅後純益 | -14,351 | -23,574 | -26,364 | -33,347 | -49,940 | -43,843 | -37,512 | -23,673 | -33,403 | -32,286 |
基本每股稅後盈餘(元) | -0.28 | -0.47 | -0.54 | -0.69 | -1.05 | -0.92 | -0.80 | -0.51 | -0.91 | -0.87 |
稀釋每股稅後盈餘(元) | -0.28 | -0.47 | -0.53 | -0.69 | -1.05 | -0.92 | -0.60 | -0.49 | -1.00 | -0.87 |
基本平均股數(千股) | 50380.00 | 50182.00 | 49230.00 | 48057.00 | 47739.00 | 47422.00 | 47030.00 | 46779.00 | 36821.00 | 37059.00 |
稀釋平均股數(千股) | 50380.00 | 50182.00 | 49230.00 | 48057.00 | 47739.00 | 47422.00 | 47030.00 | 46779.00 | 36821.00 | 37059.00 |
還原基本每股稅後盈餘(元) | -0.28 | -0.47 | -0.54 | -0.69 | -1.05 | -0.92 | -0.80 | -0.51 | -0.91 | -0.87 |
還原稀釋每股稅後盈餘(元) | -0.28 | -0.47 | -0.53 | -0.69 | -1.05 | -0.92 | -0.60 | -0.49 | -1.00 | -0.87 |
還原基本平均股數(千股) | 50,380 | 50,182 | 49,230 | 48,057 | 47,739 | 47,422 | 47,030 | 46,779 | 36,821 | 37,059 |
還原稀釋平均股數(千股) | 50,380 | 50,182 | 49,230 | 48,057 | 47,739 | 47,422 | 47,030 | 46,779 | 36,821 | 37,059 |
EBITDA(千元) | -4,239 | -21,509 | -22,164 | -30,946 | -44,663 | -39,286 | -31,976 | -22,261 | -29,716 | -30,578 |